We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A federal court has upheld a preliminary injunction preventing Watson subsidiary Andrx Pharmaceuticals from marketing clarithromycinn, a generic version of Abbott Laboratories' extended-released antibiotic Biaxin XL.
CVS's attempt to take over Caremark got a boost as the pharmaceutical services company announced it is rejecting a $26 billion bid from Express Scripts, saying it was not in the shareholders' best interests.
FTC Commissioner Jon Leibowitz has been called by Congress to present his agency's views on reverse payments at a Jan. 17 hearing being held to examine the effect of these out-of-court settlements on delaying generic market entry.
Biotech company Synosis will acquire five drug candidates that target the central nervous system as part of a new partnership with Roche, Synosis announced.
Two drugs used to treat Parkinson's disease may increase the risk for heart valve damage, according to two studies published in the New England Journal of Medicine (NEJM).
The Democrats' plan to give the federal government the authority to negotiate for lower Medicare prices has taken another step forward as the House passed H.R.4 Jan. 12 by a vote of 255-170.
Improved drug safety is foremost in the FDA's Prescription Drug User Fee Act (PDUFA) proposal that seeks new authority and more than $29 million in additional fees specifically to improve its postmarket safety surveillance.